Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer

This study has been terminated.

(Lack of NK cell expansion in 5/5 patients)

Sponsor:

Information provided by (Responsible Party):

Masonic Cancer Center, University of Minnesota

ClinicalTrials.gov Identifier:

NCT01105650

First received: April 14, 2010

Last updated: April 14, 2014

Last verified: April 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	February 2016
Primary Completion Date:	February 2014 (Final data collection date for primary outcome measure)